STEPHANIE REITTINGER: Open Payments
NPI 1013160308 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 11 payments from 7 companies in 2025. Trend: 2023 $127 · 2024 $504 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $64 |
| Cranial Technologies, Inc | 3 | $42 |
| Neurelis, Inc. | 1 | $35 |
| Gilead Sciences, Inc. | 1 | $26 |
| SANOFI PASTEUR INC. | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Doc Band, BEXSERO, VALTOCO, PENMENVY, BEYFORTUS, TZIELD, ROTATEQ.
Industry payments across CA — which companies pay providers there.
